Global Active Pharmaceutical Ingredients (API) Market Growth 2021-2026
According to this latest study, the 2021 growth of Active Pharmaceutical Ingredients (API) will have significant change from previous year. By the most conservative estimates of global Active Pharmaceutical Ingredients (API) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 66230 million in 2020. Over the next five years the Active Pharmaceutical Ingredients (API) market will register a 6.8% CAGR in terms of revenue, the global market size will reach US$ 86310 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Synthetic APIs
Biotech APIs
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy's Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredients (API) Consumption 2016-2026
2.1.2 Active Pharmaceutical Ingredients (API) Consumption CAGR by Region
2.2 Active Pharmaceutical Ingredients (API) Segment by Type
2.2.1 Synthetic APIs
2.2.2 Biotech APIs
2.3 Active Pharmaceutical Ingredients (API) Sales by Type
2.3.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2016-2021)
2.4 Active Pharmaceutical Ingredients (API) Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Active Pharmaceutical Ingredients (API) Sales by Application
2.5.1 Global Active Pharmaceutical Ingredients (API) Sale Market Share by Application (2016-2021)
2.5.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2016-2021)
3 Global Active Pharmaceutical Ingredients (API) by Company
3.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company
3.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Company (2019-2021)
3.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2019-2021)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company
3.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Company (2019-2021)
3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2019-2021)
3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Company
3.4 Global Manufacturers Active Pharmaceutical Ingredients (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Pharmaceutical Ingredients (API) Product Location Distribution
3.4.2 Players Active Pharmaceutical Ingredients (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Active Pharmaceutical Ingredients (API) by Region
4.1 Global Active Pharmaceutical Ingredients (API) by Region
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Region
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region
4.2 Americas Active Pharmaceutical Ingredients (API) Sales Growth
4.3 APAC Active Pharmaceutical Ingredients (API) Sales Growth
4.4 Europe Active Pharmaceutical Ingredients (API) Sales Growth
4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Growth
5 Americas
5.1 Americas Active Pharmaceutical Ingredients (API) Sales by Country
5.1.1 Americas Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
5.1.2 Americas Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
5.2 Americas Active Pharmaceutical Ingredients (API) Sales by Type
5.3 Americas Active Pharmaceutical Ingredients (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredients (API) Sales by Region
6.1.1 APAC Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021)
6.1.2 APAC Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021)
6.2 APAC Active Pharmaceutical Ingredients (API) Sales by Type
6.3 APAC Active Pharmaceutical Ingredients (API) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Active Pharmaceutical Ingredients (API) by Country
7.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
7.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
7.2 Europe Active Pharmaceutical Ingredients (API) Sales by Type
7.3 Europe Active Pharmaceutical Ingredients (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) by Country
8.1.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Active Pharmaceutical Ingredients (API) Distributors
10.3 Active Pharmaceutical Ingredients (API) Customer
11 Global Active Pharmaceutical Ingredients (API) Market Forecast
11.1 Global Active Pharmaceutical Ingredients (API) Forecast by Region
11.1.1 Global Active Pharmaceutical Ingredients (API) Forecast by Regions (2021-2026)
11.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Active Pharmaceutical Ingredients (API) Forecast by Type
11.7 Global Active Pharmaceutical Ingredients (API) Forecast by Application
12 Key Players Analysis
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Active Pharmaceutical Ingredients (API) Product Offered
12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Teva Main Business Overview
12.1.5 Teva Latest Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Active Pharmaceutical Ingredients (API) Product Offered
12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Mylan Main Business Overview
12.2.5 Mylan Latest Developments
12.3 DSM
12.3.1 DSM Company Information
12.3.2 DSM Active Pharmaceutical Ingredients (API) Product Offered
12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 DSM Main Business Overview
12.3.5 DSM Latest Developments
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Company Information
12.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Offered
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Aurobindo Pharma Main Business Overview
12.4.5 Aurobindo Pharma Latest Developments
12.5 Aspen
12.5.1 Aspen Company Information
12.5.2 Aspen Active Pharmaceutical Ingredients (API) Product Offered
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aspen Main Business Overview
12.5.5 Aspen Latest Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Active Pharmaceutical Ingredients (API) Product Offered
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Novartis Main Business Overview
12.6.5 Novartis Latest Developments
12.7 BASF
12.7.1 BASF Company Information
12.7.2 BASF Active Pharmaceutical Ingredients (API) Product Offered
12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 BASF Main Business Overview
12.7.5 BASF Latest Developments
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Active Pharmaceutical Ingredients (API) Product Offered
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Pfizer Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Company Information
12.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Huahai Pharmaceutical Main Business Overview
12.9.5 Huahai Pharmaceutical Latest Developments
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Company Information
12.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hisun Pharmaceutical Main Business Overview
12.10.5 Hisun Pharmaceutical Latest Developments
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Company Information
12.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Offered
12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Sun Pharmaceutical Industries Main Business Overview
12.11.5 Sun Pharmaceutical Industries Latest Developments
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Company Information
12.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Offered
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Zhejiang Medicine Main Business Overview
12.12.5 Zhejiang Medicine Latest Developments
12.13 Dr. Reddy's Laboratories
12.13.1 Dr. Reddy's Laboratories Company Information
12.13.2 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Product Offered
12.13.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Dr. Reddy's Laboratories Main Business Overview
12.13.5 Dr. Reddy's Laboratories Latest Developments
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Company Information
12.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Offered
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Zhejiang NHU Main Business Overview
12.14.5 Zhejiang NHU Latest Developments
12.15 Bayer
12.15.1 Bayer Company Information
12.15.2 Bayer Active Pharmaceutical Ingredients (API) Product Offered
12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Bayer Main Business Overview
12.15.5 Bayer Latest Developments
12.16 NCPC
12.16.1 NCPC Company Information
12.16.2 NCPC Active Pharmaceutical Ingredients (API) Product Offered
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 NCPC Main Business Overview
12.16.5 NCPC Latest Developments
12.17 AbbVie
12.17.1 AbbVie Company Information
12.17.2 AbbVie Active Pharmaceutical Ingredients (API) Product Offered
12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 AbbVie Main Business Overview
12.17.5 AbbVie Latest Developments
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Company Information
12.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Shandong Xinhua Pharmaceutical Main Business Overview
12.18.5 Shandong Xinhua Pharmaceutical Latest Developments
12.19 Northeast Pharm
12.19.1 Northeast Pharm Company Information
12.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Offered
12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Northeast Pharm Main Business Overview
12.19.5 Northeast Pharm Latest Developments
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Company Information
12.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Harbin Pharmaceutical Main Business Overview
12.20.5 Harbin Pharmaceutical Latest Developments
12.21 LKPC
12.21.1 LKPC Company Information
12.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Offered
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 LKPC Main Business Overview
12.21.5 LKPC Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Active Pharmaceutical Ingredients (API) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Synthetic APIs
Table 3. Major Players of Biotech APIs
Table 4. Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (Tons)
Table 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 6. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
Table 8. Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2016-2021)
Table 9. Global Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (Tons)
Table 10. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 11. Global Active Pharmaceutical Ingredients (API) Value by Application (2016-2021)
Table 12. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2021)
Table 13. Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2016-2021)
Table 14. Global Active Pharmaceutical Ingredients (API) Sales by Company (2019-2021) & (Tons)
Table 15. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2019-2021)
Table 16. Global Active Pharmaceutical Ingredients (API) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2019-2021)
Table 18. Global Active Pharmaceutical Ingredients (API) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Active Pharmaceutical Ingredients (API) Producing Area Distribution and Sales Area
Table 20. Players Active Pharmaceutical Ingredients (API) Products Offered
Table 21. Active Pharmaceutical Ingredients (API) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) (Tons)
Table 25. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Table 26. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Table 28. Americas Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 29. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 30. Americas Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 32. Americas Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (Tons)
Table 33. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 34. Americas Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (Tons)
Table 35. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 36. APAC Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (Tons)
Table 37. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Table 38. APAC Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Table 40. APAC Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (Tons)
Table 41. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 42. APAC Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (Tons)
Table 43. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 44. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 45. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 46. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 48. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (Tons)
Table 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 50. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (Tons)
Table 51. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 53. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (Tons)
Table 57. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (Tons)
Table 59. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Active Pharmaceutical Ingredients (API)
Table 61. Key Application and Potential Industries of Active Pharmaceutical Ingredients (API)
Table 62. Key Challenges of Active Pharmaceutical Ingredients (API)
Table 63. Key Trends of Active Pharmaceutical Ingredients (API)
Table 64. Active Pharmaceutical Ingredients (API) Distributors List
Table 65. Active Pharmaceutical Ingredients (API) Customer List
Table 66. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2021-2026) & (Tons)
Table 67. Global Active Pharmaceutical Ingredients (API) Consumption Market Forecast by Region
Table 68. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) & (Tons)
Table 71. Americas Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2021-2026) & (Tons)
Table 73. APAC Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) & (Tons)
Table 75. Europe Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) & (Tons)
Table 77. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2021-2026) & (Tons)
Table 79. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2021-2026) & (Tons)
Table 83. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Application (2021-2026)
Table 86. Teva Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 87. Teva Active Pharmaceutical Ingredients (API) Product Offered
Table 88. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 89. Teva Main Business
Table 90. Teva Latest Developments
Table 91. Mylan Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 92. Mylan Active Pharmaceutical Ingredients (API) Product Offered
Table 93. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 94. Mylan Main Business
Table 95. Mylan Latest Developments
Table 96. DSM Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 97. DSM Active Pharmaceutical Ingredients (API) Product Offered
Table 98. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 99. DSM Main Business
Table 100. DSM Latest Developments
Table 101. Aurobindo Pharma Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 102. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Offered
Table 103. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 104. Aurobindo Pharma Main Business
Table 105. Aurobindo Pharma Latest Developments
Table 106. Aspen Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 107. Aspen Active Pharmaceutical Ingredients (API) Product Offered
Table 108. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 109. Aspen Main Business
Table 110. Aspen Latest Developments
Table 111. Novartis Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 112. Novartis Active Pharmaceutical Ingredients (API) Product Offered
Table 113. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 114. Novartis Main Business
Table 115. Novartis Latest Developments
Table 116. BASF Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 117. BASF Active Pharmaceutical Ingredients (API) Product Offered
Table 118. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 119. BASF Main Business
Table 120. BASF Latest Developments
Table 121. Pfizer Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer Active Pharmaceutical Ingredients (API) Product Offered
Table 123. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 124. Pfizer Main Business
Table 125. Pfizer Latest Developments
Table 126. Huahai Pharmaceutical Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 127. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
Table 128. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 129. Huahai Pharmaceutical Main Business
Table 130. Huahai Pharmaceutical Latest Developments
Table 131. Hisun Pharmaceutical Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 132. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
Table 133. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 134. Hisun Pharmaceutical Main Business
Table 135. Hisun Pharmaceutical Latest Developments
Table 136. Sun Pharmaceutical Industries Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 137. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Offered
Table 138. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 139. Sun Pharmaceutical Industries Main Business
Table 140. Sun Pharmaceutical Industries Latest Developments
Table 141. Zhejiang Medicine Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 142. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Offered
Table 143. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 144. Zhejiang Medicine Main Business
Table 145. Zhejiang Medicine Latest Developments
Table 146. Dr. Reddy's Laboratories Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 147. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Product Offered
Table 148. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 149. Dr. Reddy's Laboratories Main Business
Table 150. Dr. Reddy's Laboratories Latest Developments
Table 151. Zhejiang NHU Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 152. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Offered
Table 153. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 154. Zhejiang NHU Main Business
Table 155. Zhejiang NHU Latest Developments
Table 156. Bayer Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 157. Bayer Active Pharmaceutical Ingredients (API) Product Offered
Table 158. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 159. Bayer Main Business
Table 160. Bayer Latest Developments
Table 161. NCPC Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 162. NCPC Active Pharmaceutical Ingredients (API) Product Offered
Table 163. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 164. NCPC Main Business
Table 165. NCPC Latest Developments
Table 166. AbbVie Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 167. AbbVie Active Pharmaceutical Ingredients (API) Product Offered
Table 168. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 169. AbbVie Main Business
Table 170. AbbVie Latest Developments
Table 171. Shandong Xinhua Pharmaceutical Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 172. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
Table 173. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 174. Shandong Xinhua Pharmaceutical Main Business
Table 175. Shandong Xinhua Pharmaceutical Latest Developments
Table 176. Northeast Pharm Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 177. Northeast Pharm Active Pharmaceutical Ingredients (API) Product Offered
Table 178. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 179. Northeast Pharm Main Business
Table 180. Northeast Pharm Latest Developments
Table 181. Harbin Pharmaceutical Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 182. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offered
Table 183. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 184. Harbin Pharmaceutical Main Business
Table 185. Harbin Pharmaceutical Latest Developments
Table 186. LKPC Basic Information, Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors
Table 187. LKPC Active Pharmaceutical Ingredients (API) Product Offered
Table 188. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2019-2021E)
Table 189. LKPC Main Business
Table 190. LKPC Latest Developments
List of Figures
Figure 1. Picture of Active Pharmaceutical Ingredients (API)
Figure 2. Active Pharmaceutical Ingredients (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2026 (Tons)
Figure 7. Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Active Pharmaceutical Ingredients (API) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Synthetic APIs
Figure 10. Product Picture of Biotech APIs
Figure 11. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 12. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
Figure 13. Active Pharmaceutical Ingredients (API) Consumed in CNS
Figure 14. Global Active Pharmaceutical Ingredients (API) Market: CNS (2016-2021) & (Tons)
Figure 15. Active Pharmaceutical Ingredients (API) Consumed in Cardiovascular
Figure 16. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular (2016-2021) & (Tons)
Figure 17. Active Pharmaceutical Ingredients (API) Consumed in Genitourinary/Hormonal Drugs
Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Genitourinary/Hormonal Drugs (2016-2021) & (Tons)
Figure 19. Active Pharmaceutical Ingredients (API) Consumed in Respiratory
Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Respiratory (2016-2021) & (Tons)
Figure 21. Active Pharmaceutical Ingredients (API) Consumed in Rheumatology
Figure 22. Global Active Pharmaceutical Ingredients (API) Market: Rheumatology (2016-2021) & (Tons)
Figure 23. Active Pharmaceutical Ingredients (API) Consumed in Diabetes
Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Diabetes (2016-2021) & (Tons)
Figure 25. Active Pharmaceutical Ingredients (API) Consumed in Oncology
Figure 26. Global Active Pharmaceutical Ingredients (API) Market: Oncology (2016-2021) & (Tons)
Figure 27. Active Pharmaceutical Ingredients (API) Consumed in Others
Figure 28. Global Active Pharmaceutical Ingredients (API) Market: Others (2016-2021) & (Tons)
Figure 29. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Figure 30. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application in 2020
Figure 31. Active Pharmaceutical Ingredients (API) Revenue Market by Company in 2020 ($ Million)
Figure 32. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company in 2020
Figure 33. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2016-2021)
Figure 34. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2020
Figure 35. Americas Active Pharmaceutical Ingredients (API) Sales 2016-2021 (Tons)
Figure 36. Americas Active Pharmaceutical Ingredients (API) Revenue 2016-2021 ($ Millions)
Figure 37. APAC Active Pharmaceutical Ingredients (API) Sales 2016-2021 (Tons)
Figure 38. APAC Active Pharmaceutical Ingredients (API) Revenue 2016-2021 ($ Millions)
Figure 39. Europe Active Pharmaceutical Ingredients (API) Sales 2016-2021 (Tons)
Figure 40. Europe Active Pharmaceutical Ingredients (API) Revenue 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales 2016-2021 (Tons)
Figure 42. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue 2016-2021 ($ Millions)
Figure 43. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 44. Americas Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 45. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 46. Americas Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 47. United States Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Canada Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Mexico Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Brazil Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 51. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2020
Figure 52. APAC Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions in 2020
Figure 53. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 54. APAC Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 55. China Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Japan Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Korea Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 59. India Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Australia Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 61. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 62. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 63. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 64. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 65. Germany Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 66. France Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 67. UK Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 68. Italy Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 69. Russia Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 70. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 71. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 72. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 73. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 74. Egypt Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 75. South Africa Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 76. Israel Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 77. Turkey Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 78. GCC Country Active Pharmaceutical Ingredients (API) Revenue Growth 2016-2021 ($ Millions)
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets